Pre-clinical models of infectious diseases - task area c
Active Awarded Last action
- Contract number
- 75N93024D00013
- Awardee
-
Institute For Clinical Pharmacodynamics, Inc. UEI Z82HHPY83MC7
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $111,080 obligated
Award facts
- Opportunity
-
- Pre-Clinical Models of Infectious Diseases Pre-Solicitation · NIHAI75N93023R00003 · Posted Oct 21, 2022
- Combined order value
-
- $111,080 Current, with exercised options
- $333,240 Potential, with all options
- Last date to order 33% complete
- IDV ceiling <1% used
- $146,300,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 76 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded an indefinite-delivery contract to Institute For Clinical Pharmacodynamics, Inc. with a ceiling of $146.3 million and an award date of July 15, 2024. This is one of multiple awards under the Pre-Clinical Models of Infectious Diseases program.
Institute For Clinical Pharmacodynamics, Inc. is a minority-owned, for-profit organization based in Schenectady, New York. The contract runs through July 14, 2031 and covers Task Area C of the Pre-Clinical Models of Infectious Diseases program.
Under this IDIQ, the contractor provides preclinical models of infectious diseases, including animal model studies, pathogen production and characterization, and evaluation of candidate countermeasures against RNA viruses with pandemic potential, antimicrobial-resistant infections, and emerging pathogens designated by NIAID. Work is performed in support of regulatory science and preclinical infectious disease research within the Department of Health and Human Services.
The originating pre-solicitation was posted October 21, 2022 with a due date of November 7, 2022. The contractor operates within biotechnology research and development (NAICS 541714) and health research and development services (PSC AJ11). As of the source data, the contract remains in early execution phase with modest task order activity to date.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| C02 - PK-PD analysis of mouse model efficacy and PK data for antibacterial compounds | National Institute of Allergy and Infectious Diseases (NIH) | $111,080 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93024D00013?
75N93024D00013 was awarded to Institute For Clinical Pharmacodynamics, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 15, 2024.
How much is contract 75N93024D00013 worth?
Orders under 75N93024D00013 have obligated $111,080. Their combined potential value, with all options, is $333,240. 75N93024D00013's own ceiling is $146,300,000.
How many orders have been placed under contract 75N93024D00013?
1 order has been placed under 75N93024D00013, the latest on September 25, 2026.
Who can order from contract 75N93024D00013?
75N93024D00013 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93024D00013 part of a contract vehicle?
Yes. 75N93024D00013 is part of Pre-Clinical Models of Infectious Diseases.
Was contract 75N93024D00013 competed?
The extent of competition for 75N93024D00013 was full and open competition. The government received 76 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV